Emodin alleviates high glucose-induced oxidative stress, inflammation and extracellular matrix accumulation of mesangial cells by the circ_0000064/miR-30c-5p/Lmp7 axis

References

• Umanath K, Lewis JB. Update on Diabetic Nephropathy: Core Curriculum 2018. Am J Kidney Dis. 2018;71(6):884–895.
   PubMed Web of Science ®Google Scholar
• Tung CW, Hsu YC, Shih YH, et al. Glomerular mesangial cell and podocyte injuries in diabetic nephropathy. Nephrology (Carlton). 2018;23(Suppl 4):32–37.
   PubMed Web of Science ®Google Scholar
• Al Hroob AM, Abukhalil MH, Alghonmeen RD, et al. Ginger alleviates hyperglycemia-induced oxidative stress, inflammation and apoptosis and protects rats against diabetic nephropathy. Biomed Pharmacother. 2018;106:381–389.
   PubMed Web of Science ®Google Scholar
• Choudhury D, Tuncel M, Levi M. Diabetic nephropathy – a multifaceted target of new therapies. Discov Med. 2010;10(54):406–415.
   PubMed Web of Science ®Google Scholar
• Dong X, Fu J, Yin X, et al. Emodin: a review of its pharmacology, toxicity and pharmacokinetics. Phytother Res. 2016;30(8):1207–1218.
   PubMed Web of Science ®Google Scholar
• Cui Y, Chen LJ, Huang T, et al. The pharmacology, toxicology and therapeutic potential of anthraquinone derivative emodin. Chin J Nat Med. 2020;18(6):425–435.
   PubMed Web of Science ®Google Scholar
• Gao J, Wang F, Wang W, et al. Emodin suppresses hyperglycemia-induced proliferation and fibronectin expression in mesangial cells via inhibiting cFLIP. PLoS One. 2014;9(4):e93588.
   PubMed Web of Science ®Google Scholar
• Yang J, Zeng Z, Wu T, et al. Emodin attenuates high glucose-induced TGF-β1 and fibronectin expression in mesangial cells through inhibition of NF-κB pathway. Exp Cell Res. 2013;319(20):3182–3189.
   PubMed Web of Science ®Google Scholar
• Li X, Liu W, Wang Q, et al. Emodin suppresses cell proliferation and fibronectin expression via p38MAPK pathway in rat mesangial cells cultured under high glucose. Mol Cell Endocrinol. 2009;307(1–2):157–162.
   PubMed Web of Science ®Google Scholar
• Kristensen LS, Andersen MS, Stagsted LVW, et al. The biogenesis, biology and characterization of circular RNAs. Nat Rev Genet. 2019;20(11):675–691.
   PubMed Web of Science ®Google Scholar
• Loganathan TS, Sulaiman SA, Abdul Murad NA, et al. Interactions among non-coding RNAs in diabetic nephropathy. Front Pharmacol. 2020;11:191.
   PubMed Web of Science ®Google Scholar
• Hu W, Han Q, Zhao L, et al. Circular RNA circRNA_15698 aggravates the extracellular matrix of diabetic nephropathy mesangial cells via miR-185/TGF-β1. J Cell Physiol. 2019;234(2):1469–1476.
   PubMed Web of Science ®Google Scholar
• Chen B, Li Y, Liu Y, et al. circLRP6 regulates high glucose-induced proliferation, oxidative stress, ECM accumulation, and inflammation in mesangial cells. J Cell Physiol. 2019;234(11):21249–21259.
   PubMed Web of Science ®Google Scholar
• Ge X, Xi L, Wang Q, et al. Circular RNA Circ_0000064 promotes the proliferation and fibrosis of mesangial cells via miR-143 in diabetic nephropathy. Gene. 2020;758:144952.
   PubMed Web of Science ®Google Scholar
• Mahajan SD, Schwartz SA, Nair MP. Immunological assays for chemokine detection in in-vitro culture of CNS cells. Biol Proced Online. 2003;5:90–102.
   PubMedGoogle Scholar
• Sun Y, Peng R, Peng H, et al. miR-451 suppresses the NF-kappaB-mediated proinflammatory molecules expression through inhibiting LMP7 in diabetic nephropathy. Mol Cell Endocrinol. 2016;433:75–86.
   PubMed Web of Science ®Google Scholar
• Hao QF, Wang BB, Zhang W, et al. NF-κB inhibitor parthenolide promotes renal tubules albumin uptake in type 2 diabetic nephropathy. Chin Med Sci J. 2020;35(1):31–42.
   PubMedGoogle Scholar
• Manna K, Mishra S, Saha M, et al. Amelioration of diabetic nephropathy using pomegranate peel extract-stabilized gold nanoparticles: assessment of NF-κB and Nrf2 signaling system. Int J Nanomed. 2019;14:1753–1777.
   PubMed Web of Science ®Google Scholar
• Ma Y, Chen F, Yang S, et al. Silencing of TRB3 ameliorates diabetic tubule interstitial nephropathy via PI3K/AKT signaling in rats. Med Sci Monit. 2017;23:2816–2824.
   PubMed Web of Science ®Google Scholar
• Qian X, He L, Hao M, et al. YAP mediates the interaction between the Hippo and PI3K/Akt pathways in mesangial cell proliferation in diabetic nephropathy. Acta Diabetol. 2021;58(1):47–62.
   PubMed Web of Science ®Google Scholar
• Jing D, Bai H, Yin S. Renoprotective effects of emodin against diabetic nephropathy in rat models are mediated via PI3K/Akt/GSK-3β and Bax/caspase-3 signaling pathways. Exp Ther Med. 2017;14(5):5163–5169.
   PubMed Web of Science ®Google Scholar
• Tian N, Gao Y, Wang X, et al. Emodin mitigates podocytes apoptosis induced by endoplasmic reticulum stress through the inhibition of the PERK pathway in diabetic nephropathy. Drug Des Dev Ther. 2018;12:2195–2211.
   PubMed Web of Science ®Google Scholar
• Wu L, Xu XM, Li Y, et al. Circ_0000064 adsorption of microRNA-143 promotes malignant progression of hepatocellular carcinoma. Eur Rev Med Pharmacol Sci. 2019;23(21):9321–9330.
   PubMed Web of Science ®Google Scholar
• Luo YH, Zhu XZ, Huang KW, et al. Emerging roles of circular RNA hsa_circ_0000064 in the proliferation and metastasis of lung cancer. Biomed Pharmacother. 2017;96:892–898.
   PubMed Web of Science ®Google Scholar
• Jin P, Li LH, Shi Y, et al. Salidroside inhibits apoptosis and autophagy of cardiomyocyte by regulation of circular RNA hsa_circ_0000064 in cardiac ischemia-reperfusion injury. Gene. 2020;767:145075.
   PubMed Web of Science ®Google Scholar
• Wang X, Zhang Y, Han S, et al. Overexpression of miR‑30c‑5p reduces cellular cytotoxicity and inhibits the formation of kidney stones through ATG5. Int J Mol Med. 2020;45(2):375–384.
   PubMed Web of Science ®Google Scholar
• Li X, Yao L, Zeng X, et al. miR-30c-5p alleviated pyroptosis during sepsis-induced acute kidney injury via targeting TXNIP. Inflammation. 2021;44(1):217–228.
   PubMed Web of Science ®Google Scholar
• Song S, Long M, Yu G, et al. Urinary exosome miR-30c-5p as a biomarker of clear cell renal cell carcinoma that inhibits progression by targeting HSPA5. J Cell Mol Med. 2019;23(10):6755–6765.
   PubMed Web of Science ®Google Scholar
• Fu JX, Sun GQ, Wang HL, et al. LncRNA OIP5-AS1 induces epithelial-to-mesenchymal transition and renal fibrosis in diabetic nephropathy via binding to miR-30c-5p. J Biol Regul Homeost Agents. 2020;34(3):961–968.
   PubMed Web of Science ®Google Scholar
• Gao BH, Wu H, Wang X, et al. MiR-30c-5p inhibits high glucose-induced EMT and renal fibrogenesis by down-regulation of JAK1 in diabetic nephropathy. Eur Rev Med Pharmacol Sci. 2020;24(3):1338–1349.
   PubMed Web of Science ®Google Scholar
• Zhao Y, Yin Z, Li H, et al. MiR-30c protects diabetic nephropathy by suppressing epithelial-to-mesenchymal transition in db/db mice. Aging Cell. 2017;16(2):387–400.
   PubMed Web of Science ®Google Scholar
• Hewing B, Ludwig A, Dan C, et al. Immunoproteasome subunit ß5i/LMP7-deficiency in atherosclerosis. Sci Rep. 2017;7(1):13342.
   PubMedGoogle Scholar
• Muchamuel T, Basler M, Aujay MA, et al. A selective inhibitor of the immunoproteasome subunit LMP7 blocks cytokine production and attenuates progression of experimental arthritis. Nat Med. 2009;15(7):781–787.
   PubMed Web of Science ®Google Scholar
• Lee M, Song IH, Heo SH, et al. Expression of immunoproteasome subunit LMP7 in breast cancer and its association with immune-related markers. Cancer Res Treat. 2019;51(1):80–89.
   PubMed Web of Science ®Google Scholar
• Ding H, Cheng H, Fu Z, et al. Relationship of large multifunctional proteasome 7 gene polymorphism with susceptibility to type 1 diabetes mellitus and DR3 gene. Chin Med J (Engl). 2001;114(12):1263–1266.
   PubMed Web of Science ®Google Scholar